GALLOWAY CHRISTOPHER D 4
4 · Diffusion Pharmaceuticals Inc. · Filed Jan 31, 2022
Insider Transaction Report
Form 4
GALLOWAY CHRISTOPHER D
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-27+305,743→ 305,743 totalExercise: $0.24Exp: 2032-01-27→ Common Stock (305,743 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022.